MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, in Advanced NSCLC ...
Zacks Investment Research on MSN
VKTX completes enrollment in phase I maintenance study of obesity drug
Viking Therapeutics VKTX announced that it has completed enrolling patients in its exploratory maintenance dosing study of ...
Galea, H. , Perry, M. and Jones, P. (2026) Characterising Irritable Bowel Syndrome: An Exploratory Cross-Sectional Study .
IMMUNOLIFE, a Phase 2 randomized exploratory study, will evaluate the potential of MaaT033 in combination with Cemiplimab versus Best Investigator Choice (i.e.: second line) in enhancing disease ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced ...
In this study, 3,319 unselected, pan-cancer Jordanian patients diagnosed between April 2021 and September 2022 received GGT. Pathogenic germline variant (PGV) frequency among patients who were ...
In a recent study published in the journal Mindfulness, researchers examine the prevalence and effects of emergent phenomena (EP), their forms, the balance of positive and negative repercussions, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback